CTLA-4 polymorphisms and systemic lupus erythematosus (SLE)

A meta-analysis

Young Ho Lee, John B. Harley, Swapan K. Nath

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Several reports demonstrate association between variants of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune diseases. CTLA-4 may generate autoimmunity by immune dysregulation, making CTLA-4 an attractive candidate gene for systemic lupus erythematosus (SLE) susceptibility. Previous CTLA-4 association studies with SLE, however, have produced inconsistent results. We have performed a meta-analysis to better assess the purported associations. A total of 14 independent studies (to July 2004) testing association between one or more CTLA-4 polymorphisms and SLE were used in this analysis. We have compared allele and genotype frequencies at four polymorphic sites found in exon-1 (at +49), the promoter region (at -318 and -722), and the 3′ untranslated region (3′UTR) (dinucleotide repeat). We have evaluated both fixed and random effect models, depending on the presence of between-study heterogeneity. The data demonstrate that the exon-1 +49 polymorphism is significantly associated with SLE susceptibility. The overall risk, measured by odds ratio (OR), for exon-1 +49 GG genotype is 1.287 [95% confidence interval (CI) = 1.031-1.562, P = 0.011]. Stratification by ethnicity indicates the exon-1 +49 GG genotype is associated with SLE, at least in Asians (OR=1.293, 95% CI = 1.031-1.620, P = 0.026). European-derived populations have an effect of similar magnitude (OR = 1.268, 95% CI = 0.860-1.870, P = 0.230), though not significant. Similar trends are found in allele-specific risk estimates and disease association. The OR for the exon-1 +49 risk allele (G) in Asians is 1.246 (95% CI = 1.057-1.469, P = 0.009), while Europeans have no evidence of allelic association (OR = 0.978, 95% CI = 0.833-1.148, P = 0.780). In conclusion, this meta-analysis supports the CTLA-4 exon-1 +49 (A/G) polymorphism influencing the risk for developing SLE, especially in Asians.

Original languageEnglish
Pages (from-to)361-367
Number of pages7
JournalHuman Genetics
Volume116
Issue number5
DOIs
Publication statusPublished - 2005 Apr 1
Externally publishedYes

Fingerprint

CTLA-4 Antigen
Systemic Lupus Erythematosus
Meta-Analysis
Exons
Odds Ratio
Confidence Intervals
Genotype
Alleles
Dinucleotide Repeats
3' Untranslated Regions
Autoimmunity
Genetic Promoter Regions
Gene Frequency
Autoimmune Diseases
Population
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

CTLA-4 polymorphisms and systemic lupus erythematosus (SLE) : A meta-analysis. / Lee, Young Ho; Harley, John B.; Nath, Swapan K.

In: Human Genetics, Vol. 116, No. 5, 01.04.2005, p. 361-367.

Research output: Contribution to journalArticle

Lee, Young Ho ; Harley, John B. ; Nath, Swapan K. / CTLA-4 polymorphisms and systemic lupus erythematosus (SLE) : A meta-analysis. In: Human Genetics. 2005 ; Vol. 116, No. 5. pp. 361-367.
@article{82ece8f63a6a471d909f8d62351a1193,
title = "CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): A meta-analysis",
abstract = "Several reports demonstrate association between variants of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune diseases. CTLA-4 may generate autoimmunity by immune dysregulation, making CTLA-4 an attractive candidate gene for systemic lupus erythematosus (SLE) susceptibility. Previous CTLA-4 association studies with SLE, however, have produced inconsistent results. We have performed a meta-analysis to better assess the purported associations. A total of 14 independent studies (to July 2004) testing association between one or more CTLA-4 polymorphisms and SLE were used in this analysis. We have compared allele and genotype frequencies at four polymorphic sites found in exon-1 (at +49), the promoter region (at -318 and -722), and the 3′ untranslated region (3′UTR) (dinucleotide repeat). We have evaluated both fixed and random effect models, depending on the presence of between-study heterogeneity. The data demonstrate that the exon-1 +49 polymorphism is significantly associated with SLE susceptibility. The overall risk, measured by odds ratio (OR), for exon-1 +49 GG genotype is 1.287 [95{\%} confidence interval (CI) = 1.031-1.562, P = 0.011]. Stratification by ethnicity indicates the exon-1 +49 GG genotype is associated with SLE, at least in Asians (OR=1.293, 95{\%} CI = 1.031-1.620, P = 0.026). European-derived populations have an effect of similar magnitude (OR = 1.268, 95{\%} CI = 0.860-1.870, P = 0.230), though not significant. Similar trends are found in allele-specific risk estimates and disease association. The OR for the exon-1 +49 risk allele (G) in Asians is 1.246 (95{\%} CI = 1.057-1.469, P = 0.009), while Europeans have no evidence of allelic association (OR = 0.978, 95{\%} CI = 0.833-1.148, P = 0.780). In conclusion, this meta-analysis supports the CTLA-4 exon-1 +49 (A/G) polymorphism influencing the risk for developing SLE, especially in Asians.",
author = "Lee, {Young Ho} and Harley, {John B.} and Nath, {Swapan K.}",
year = "2005",
month = "4",
day = "1",
doi = "10.1007/s00439-004-1244-1",
language = "English",
volume = "116",
pages = "361--367",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - CTLA-4 polymorphisms and systemic lupus erythematosus (SLE)

T2 - A meta-analysis

AU - Lee, Young Ho

AU - Harley, John B.

AU - Nath, Swapan K.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Several reports demonstrate association between variants of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune diseases. CTLA-4 may generate autoimmunity by immune dysregulation, making CTLA-4 an attractive candidate gene for systemic lupus erythematosus (SLE) susceptibility. Previous CTLA-4 association studies with SLE, however, have produced inconsistent results. We have performed a meta-analysis to better assess the purported associations. A total of 14 independent studies (to July 2004) testing association between one or more CTLA-4 polymorphisms and SLE were used in this analysis. We have compared allele and genotype frequencies at four polymorphic sites found in exon-1 (at +49), the promoter region (at -318 and -722), and the 3′ untranslated region (3′UTR) (dinucleotide repeat). We have evaluated both fixed and random effect models, depending on the presence of between-study heterogeneity. The data demonstrate that the exon-1 +49 polymorphism is significantly associated with SLE susceptibility. The overall risk, measured by odds ratio (OR), for exon-1 +49 GG genotype is 1.287 [95% confidence interval (CI) = 1.031-1.562, P = 0.011]. Stratification by ethnicity indicates the exon-1 +49 GG genotype is associated with SLE, at least in Asians (OR=1.293, 95% CI = 1.031-1.620, P = 0.026). European-derived populations have an effect of similar magnitude (OR = 1.268, 95% CI = 0.860-1.870, P = 0.230), though not significant. Similar trends are found in allele-specific risk estimates and disease association. The OR for the exon-1 +49 risk allele (G) in Asians is 1.246 (95% CI = 1.057-1.469, P = 0.009), while Europeans have no evidence of allelic association (OR = 0.978, 95% CI = 0.833-1.148, P = 0.780). In conclusion, this meta-analysis supports the CTLA-4 exon-1 +49 (A/G) polymorphism influencing the risk for developing SLE, especially in Asians.

AB - Several reports demonstrate association between variants of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune diseases. CTLA-4 may generate autoimmunity by immune dysregulation, making CTLA-4 an attractive candidate gene for systemic lupus erythematosus (SLE) susceptibility. Previous CTLA-4 association studies with SLE, however, have produced inconsistent results. We have performed a meta-analysis to better assess the purported associations. A total of 14 independent studies (to July 2004) testing association between one or more CTLA-4 polymorphisms and SLE were used in this analysis. We have compared allele and genotype frequencies at four polymorphic sites found in exon-1 (at +49), the promoter region (at -318 and -722), and the 3′ untranslated region (3′UTR) (dinucleotide repeat). We have evaluated both fixed and random effect models, depending on the presence of between-study heterogeneity. The data demonstrate that the exon-1 +49 polymorphism is significantly associated with SLE susceptibility. The overall risk, measured by odds ratio (OR), for exon-1 +49 GG genotype is 1.287 [95% confidence interval (CI) = 1.031-1.562, P = 0.011]. Stratification by ethnicity indicates the exon-1 +49 GG genotype is associated with SLE, at least in Asians (OR=1.293, 95% CI = 1.031-1.620, P = 0.026). European-derived populations have an effect of similar magnitude (OR = 1.268, 95% CI = 0.860-1.870, P = 0.230), though not significant. Similar trends are found in allele-specific risk estimates and disease association. The OR for the exon-1 +49 risk allele (G) in Asians is 1.246 (95% CI = 1.057-1.469, P = 0.009), while Europeans have no evidence of allelic association (OR = 0.978, 95% CI = 0.833-1.148, P = 0.780). In conclusion, this meta-analysis supports the CTLA-4 exon-1 +49 (A/G) polymorphism influencing the risk for developing SLE, especially in Asians.

UR - http://www.scopus.com/inward/record.url?scp=17144378972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144378972&partnerID=8YFLogxK

U2 - 10.1007/s00439-004-1244-1

DO - 10.1007/s00439-004-1244-1

M3 - Article

VL - 116

SP - 361

EP - 367

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 5

ER -